Metabolism of flavonolignans in human hepatocytes

. 2018 Apr 15 ; 152 () : 94-101. [epub] 20180131

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid29414024
Odkazy

PubMed 29414024
DOI 10.1016/j.jpba.2018.01.048
PII: S0731-7085(17)32879-0
Knihovny.cz E-zdroje

This study examined the in vitro biotransformation of eight structurally related flavonolignans, namely silybin, 2,3-dehydrosilybin, silychristin, 2,3-dehydrosilychristin, silydianin, 2,3-dehydrosilydianin, isosilybin A and isosilybin B. The metabolic transformations were performed using primary cultures of human hepatocytes and recombinant human cytochromes P450 (CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4). The metabolites produced were analyzed by ultra-performance liquid chromatography coupled with tandem mass spectrometry. We found that each of the tested compounds was metabolized in vitro by one or more CYP enzymes, which catalyzed O-demethylation, hydroxylation, hydrogenation and dehydrogenation reactions. In human hepatocytes, silybin, 2,3-dehydrosilybin, silychristin, 2,3-dehydrosilychristin, and isosilybins A and B were directly conjugated by sulfation or glucuronidation. Moreover, isosilybin A was also converted to a methyl derivative, while isosilybin B was hydroxylated and methylated. Silydianin and 2,3-dehydrosilydianin were found to undergo hydrogenation and/or glucuronidation. In addition, 2,3-dehydrosilydianin was found to be metabolically the least stable flavonolignan in human hepatocytes, and its main metabolite was a cleavage product corresponding to a loss of CO. We conclude that the hepatic biotransformation of flavonolignans primarily involves the phase II conjugation reactions, however in some cases the phase I reactions may also occur. These results are highly relevant for research focused on flavonolignan metabolism and pharmacology.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners

. 2021 Jul 23 ; 22 (15) : . [epub] 20210723

Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases

. 2021 Jun 14 ; 10 (6) : . [epub] 20210614

Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin

. 2020 Aug 12 ; 10 (8) : . [epub] 20200812

Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota

. 2020 Jan 09 ; 10 (1) : . [epub] 20200109

The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo

. 2019 Sep 24 ; 11 (10) : . [epub] 20190924

Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives

. 2019 Aug 14 ; 8 (8) : . [epub] 20190814

Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties

. 2018 Aug 09 ; 19 (8) : . [epub] 20180809

In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani

. 2018 Jun 27 ; 23 (7) : . [epub] 20180627

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...